RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Generix Group Stock

Generix Group ROE 2024

Generix Group ROE

0.07

Ticker

GENX.PA

ISIN

FR0010501692

WKN

A0MYAC

In 2024, Generix Group's return on equity (ROE) was 0.07, a -22.2% increase from the 0.1 ROE in the previous year.

Generix Group Aktienanalyse

What does Generix Group do?

Generix Group SA is a leading provider of software solutions for supply chain management and e-commerce. The company was founded in 1990 in France and has its headquarters in Paris. It employs over 1,000 employees and operates in Europe, North America, and Asia. Its business model is based on the development and sale of software solutions for optimizing supply chains and business processes. They offer a range of products including warehouse management systems, transport management systems, supply chain planning, electronic data interchange, and e-commerce platforms. The company is segmented into three business areas: supply chain collaboration, supply chain execution, and e-commerce. They offer solutions for collaboration between suppliers, customers, and partners, as well as inventory management, transportation, and delivery management. They also have platforms for online sales and distribution that cater to B2B and B2C companies. Some of their key products include collaborative supply chain management, warehouse management, and transportation management. They also develop innovative technologies such as robotic warehouses and cloud platforms for e-commerce. They are pioneers in artificial intelligence and machine learning, working closely with universities and research institutions. Overall, Generix Group SA has a strong position in the supply chain management and e-commerce solutions market, offering a wide range of products tailored to various industries. With their focus on innovation and technology, they are well positioned for future success. Generix Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Generix Group's Return on Equity (ROE)

Generix Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Generix Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Generix Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Generix Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Generix Group stock

What is the ROE (Return on Equity) of Generix Group this year?

The ROE of Generix Group this year is 0.07 undefined.

How has the Return on Equity (ROE) of Generix Group developed compared to the previous year?

The ROE of Generix Group has increased by -22.2% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Generix Group?

A high ROE indicates that Generix Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Generix Group?

A low ROE can indicate that Generix Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Generix Group affect the company?

A change in ROE (Return on Equity) of Generix Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Generix Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Generix Group?

Some factors that can influence Generix Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Generix Group pay?

Over the past 12 months, Generix Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Generix Group is expected to pay a dividend of 0 EUR.

What is the dividend yield of Generix Group?

The current dividend yield of Generix Group is .

When does Generix Group pay dividends?

Generix Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Generix Group?

Generix Group paid dividends every year for the past 0 years.

What is the dividend of Generix Group?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Generix Group located?

Generix Group is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Generix Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Generix Group from 7/31/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Generix Group pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Generix Group in the year 2023?

In the year 2023, Generix Group distributed 0 EUR as dividends.

In which currency does Generix Group pay out the dividend?

The dividends of Generix Group are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Generix Group

Our stock analysis for Generix Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Generix Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.